Jonathan Sears, MD

Appointed
1998

Education & Fellowships

Fellowship - Emory Eye Clinic
Vitreoretinal Fellowship
Atlanta, GA
1998

Residency - Yale-New Haven Hospital
Ophthalmology
New Haven, CT
1996

Internship - Yale-New Haven Hospital
Internal Medicine
New Haven, CT
1993

Medical Education - Yale University School of Medicine
MD
New Haven, CT
1992

Undergraduate - Yale University
Chemistry
New Haven, CT
1988

Professional Highlights

• AAO Achievement Award
• The Hartwell Foundation Research Fellow
• Matilda Zeigler Foundation Research Fellow

Certifications

• Ophthalmology

Specialty Interests

retinal detachment secondary to degenerative disorders such as myopia or trauma or diabetes, retinopathy of prematurity and other acquired vitreoretinal diseases, vitreoretinal diseases, pediatric retina

Awards & Honors

• Distinction in Chemistry, Department of Chemistry, Yale University, 1988$0$0Cum Laude, Yale University, 1988
• Yale Medical Student Research Fellowship, sponsored by National Institutes of Health; Howard Hughes Medical Institute, Section of Immunobiology, Yale School of Medicine, 1990-1992
• Harold J. Lamport Prize, awarded for the most creative biomedical research by a Yale medical student, Department of Biochemistry, Yale School of Medicine, 1992
• Yale Resident Research Prize, Department of Ophthalmology, 1995 and 1996
• Heed Ophthalmic Fellowship, in support of clinical research, 1997
• Emory Medical Care Fellowship, in support of basic science research, Emory University School of Medicine, 1997
• Association of University Professors of Ophthalmology, Fellow Research Competition, Finalist, 1998
• Clinical Teacher of the Year Award, Department of Ophthalmology, Emory University School of Medicine, 1998
• Clinical Investigator Development Award, Cleveland Clinic, 2003
• Best Doctors in America, 2005-2009
• Best Doctors in Cleveland, 2005-2009
• American Academy of Ophthalmology Achievement Award, 2007
• Editorial Board Member Online News and Education (O.N.E.), 2007
• Editorial Board Member British Journal of Ophthalmology
• Best Research, Poster American Academy of Ophthalmology, 2008
• Strathmore Who's Who 2009

Innovations & Patents

• Stimulating angiogenesis to prevent ischemic retinopathy

Memberships

• American Academy of Ophthalmology
• Association of Research in Vision and Ophthalmology
• International Congress of Eye Research
• Association of Pediatric Retinal Surgeons
• Cleveland Ophthalmic Society
• Heed Ophthalmic Society

See publications for Jonathan Sears, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 3/21/2025, Dr. Sears has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.